Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gata2
|
ENSMUSG00000015053.8 | GATA binding protein 2 |
Gata1
|
ENSMUSG00000031162.8 | GATA binding protein 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_7971365_7971849 | Gata1 | 3697 | 0.103187 | -0.87 | 4.2e-18 | Click! |
chrX_7970964_7971256 | Gata1 | 3200 | 0.110731 | -0.86 | 6.3e-17 | Click! |
chrX_7968340_7968526 | Gata1 | 523 | 0.581403 | -0.84 | 5.7e-16 | Click! |
chrX_7993362_7993525 | Gata1 | 15372 | 0.075825 | -0.83 | 2.5e-15 | Click! |
chrX_7966286_7966460 | Gata1 | 1537 | 0.197273 | -0.82 | 3.3e-14 | Click! |
chr6_88197979_88198182 | Gata2 | 254 | 0.877934 | 0.60 | 1.4e-06 | Click! |
chr6_88197240_88197577 | Gata2 | 926 | 0.454896 | 0.57 | 6.6e-06 | Click! |
chr6_88198217_88198368 | Gata2 | 42 | 0.962175 | 0.51 | 6.4e-05 | Click! |
chr6_88193559_88193710 | Gata2 | 257 | 0.871291 | 0.47 | 3.0e-04 | Click! |
chr6_88198764_88198966 | Gata2 | 531 | 0.682811 | 0.38 | 4.7e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_13590938_13591623 | 271.80 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
22416 |
0.14 |
chr17_13654565_13655321 | 249.87 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
13948 |
0.15 |
chr5_74905641_74905990 | 81.91 |
Gm17906 |
predicted gene, 17906 |
22480 |
0.17 |
chr17_13589870_13590228 | 69.90 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
21185 |
0.15 |
chr17_13586214_13586541 | 65.42 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
17513 |
0.15 |
chr10_125961290_125962183 | 63.07 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
4432 |
0.33 |
chr8_122284023_122284944 | 56.35 |
Zfpm1 |
zinc finger protein, multitype 1 |
2342 |
0.24 |
chr3_62348500_62348904 | 51.44 |
Arhgef26 |
Rho guanine nucleotide exchange factor (GEF) 26 |
7601 |
0.24 |
chr7_107004292_107004443 | 46.97 |
Olfr2 |
olfactory receptor 2 |
1327 |
0.26 |
chr16_14265466_14265813 | 46.79 |
Myh11 |
myosin, heavy polypeptide 11, smooth muscle |
25724 |
0.14 |
chr19_21494190_21494506 | 41.75 |
Gda |
guanine deaminase |
20903 |
0.22 |
chr7_4464545_4465001 | 41.63 |
Eps8l1 |
EPS8-like 1 |
4 |
0.94 |
chr12_26405116_26405608 | 40.95 |
Rnf144a |
ring finger protein 144A |
1085 |
0.45 |
chr17_3275020_3275269 | 40.53 |
Gm34035 |
predicted gene, 34035 |
8063 |
0.17 |
chr14_70659174_70659883 | 39.81 |
Npm2 |
nucleophosmin/nucleoplasmin 2 |
284 |
0.85 |
chr6_30643701_30643852 | 39.42 |
Cpa1 |
carboxypeptidase A1, pancreatic |
3435 |
0.16 |
chr9_101472906_101473083 | 37.07 |
Gm5161 |
predicted pseudogene 5161 |
23641 |
0.18 |
chr7_19695060_19695492 | 36.31 |
Apoe |
apolipoprotein E |
2355 |
0.11 |
chr10_62855064_62855251 | 34.92 |
Gm48353 |
predicted gene, 48353 |
4837 |
0.13 |
chr11_43548063_43548966 | 34.72 |
Ccnjl |
cyclin J-like |
19268 |
0.13 |
chr19_34712139_34712519 | 34.07 |
Gm18425 |
predicted gene, 18425 |
2321 |
0.21 |
chr1_77469008_77469197 | 33.02 |
Mir6352 |
microRNA 6352 |
27666 |
0.19 |
chr12_108037358_108037909 | 32.89 |
Bcl11b |
B cell leukemia/lymphoma 11B |
34031 |
0.2 |
chr13_43196003_43196529 | 32.24 |
Tbc1d7 |
TBC1 domain family, member 7 |
24765 |
0.19 |
chr13_112088321_112088885 | 31.86 |
Gm31104 |
predicted gene, 31104 |
49513 |
0.12 |
chr11_95104439_95104590 | 31.80 |
Dlx3 |
distal-less homeobox 3 |
15605 |
0.12 |
chr9_107607669_107607965 | 31.65 |
Sema3b |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B |
632 |
0.4 |
chr8_102596538_102596950 | 31.36 |
Cdh11 |
cadherin 11 |
40575 |
0.15 |
chr6_39242951_39243777 | 31.15 |
Gm43479 |
predicted gene 43479 |
3250 |
0.2 |
chr17_13590288_13590503 | 30.89 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
21531 |
0.15 |
chr8_57601919_57602467 | 30.58 |
Gm45534 |
predicted gene 45534 |
4963 |
0.12 |
chr17_86476866_86477017 | 30.06 |
Prkce |
protein kinase C, epsilon |
13621 |
0.23 |
chr7_112656145_112656626 | 29.82 |
Gm45473 |
predicted gene 45473 |
3603 |
0.2 |
chr15_61805491_61805647 | 29.31 |
Gm18154 |
predicted gene, 18154 |
20678 |
0.22 |
chrX_167012030_167012225 | 29.01 |
Gm22368 |
predicted gene, 22368 |
16870 |
0.16 |
chr5_51517896_51518055 | 28.89 |
Gm43605 |
predicted gene 43605 |
3682 |
0.2 |
chr5_114591173_114591367 | 28.70 |
Fam222a |
family with sequence similarity 222, member A |
23253 |
0.13 |
chr8_84701108_84701942 | 28.65 |
Lyl1 |
lymphoblastomic leukemia 1 |
19 |
0.95 |
chr6_88190785_88190936 | 28.60 |
Gm38708 |
predicted gene, 38708 |
179 |
0.92 |
chr14_34536041_34536258 | 28.25 |
9230112D13Rik |
RIKEN cDNA 9230112D13 gene |
13348 |
0.12 |
chr16_16485604_16485955 | 28.20 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
18443 |
0.18 |
chr4_82705266_82705715 | 27.79 |
Nfib |
nuclear factor I/B |
260 |
0.93 |
chr6_36405153_36405633 | 27.73 |
9330158H04Rik |
RIKEN cDNA 9330158H04 gene |
15202 |
0.19 |
chr11_58948518_58949018 | 27.51 |
H2bu2 |
H2B.U histone 2 |
152 |
0.86 |
chr3_82946486_82946637 | 27.34 |
Rbm46os |
RNA binding motif protein 46, opposite strand |
42084 |
0.11 |
chr17_13587362_13587709 | 27.14 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
18671 |
0.15 |
chr6_93172871_93173022 | 27.13 |
Gm43923 |
predicted gene, 43923 |
21995 |
0.19 |
chr7_79148252_79148910 | 27.13 |
Mfge8 |
milk fat globule-EGF factor 8 protein |
350 |
0.87 |
chr12_3784806_3785151 | 27.03 |
Dtnb |
dystrobrevin, beta |
5430 |
0.19 |
chr9_49570435_49570586 | 27.02 |
Ncam1 |
neural cell adhesion molecule 1 |
1961 |
0.41 |
chr13_42336471_42336622 | 27.00 |
Gm47118 |
predicted gene, 47118 |
31555 |
0.19 |
chr3_53225856_53226157 | 26.97 |
Lhfp |
lipoma HMGIC fusion partner |
3319 |
0.28 |
chr15_27259054_27259330 | 26.60 |
Gm19111 |
predicted gene, 19111 |
108747 |
0.07 |
chr11_108910934_108911269 | 26.55 |
Axin2 |
axin 2 |
9248 |
0.21 |
chr2_102005743_102006102 | 26.39 |
Gm13919 |
predicted gene 13919 |
33707 |
0.17 |
chr3_121588840_121589464 | 26.37 |
A730020M07Rik |
RIKEN cDNA A730020M07 gene |
54215 |
0.09 |
chr4_119637406_119637787 | 26.25 |
Guca2a |
guanylate cyclase activator 2a (guanylin) |
108 |
0.96 |
chr15_27840550_27840894 | 26.03 |
Trio |
triple functional domain (PTPRF interacting) |
695 |
0.7 |
chr6_108472798_108472949 | 25.72 |
Gm44101 |
predicted gene, 44101 |
298 |
0.89 |
chr2_94273064_94274137 | 25.58 |
Mir670hg |
MIR670 host gene (non-protein coding) |
8682 |
0.15 |
chr2_146259190_146259362 | 25.50 |
A930019D19Rik |
RIKEN cDNA A930019D19 gene |
10 |
0.97 |
chr19_36371542_36371875 | 25.30 |
Pcgf5 |
polycomb group ring finger 5 |
7360 |
0.14 |
chr5_100108777_100109262 | 25.28 |
Tmem150c |
transmembrane protein 150C |
13777 |
0.15 |
chr13_41729696_41729998 | 24.94 |
Adtrp |
androgen dependent TFPI regulating protein |
70719 |
0.08 |
chr10_42220647_42220798 | 24.91 |
Foxo3 |
forkhead box O3 |
37644 |
0.19 |
chr5_81675096_81675247 | 24.74 |
Adgrl3 |
adhesion G protein-coupled receptor L3 |
14868 |
0.25 |
chr5_133385739_133386398 | 24.62 |
Gm42625 |
predicted gene 42625 |
57274 |
0.15 |
chr16_86838461_86838612 | 24.50 |
Gm25715 |
predicted gene, 25715 |
6934 |
0.21 |
chr12_116709666_116709817 | 24.26 |
Gm17807 |
predicted gene, 17807 |
112488 |
0.06 |
chr16_32707899_32708199 | 24.21 |
Gm9556 |
predicted gene 9556 |
18617 |
0.12 |
chr13_101914745_101915140 | 24.04 |
Gm17832 |
predicted gene, 17832 |
5478 |
0.27 |
chrX_11493886_11494235 | 23.98 |
Gm14515 |
predicted gene 14515 |
107294 |
0.06 |
chr6_125345759_125346140 | 23.71 |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
3413 |
0.15 |
chr8_46210360_46210863 | 23.58 |
Slc25a4 |
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4 |
419 |
0.73 |
chr1_64797733_64797915 | 23.37 |
Plekhm3 |
pleckstrin homology domain containing, family M, member 3 |
38940 |
0.13 |
chr10_14168270_14168768 | 23.25 |
Gm28289 |
predicted gene 28289 |
14073 |
0.17 |
chr4_67167820_67168015 | 23.11 |
Gm11403 |
predicted gene 11403 |
2438 |
0.46 |
chr5_119836588_119836964 | 23.09 |
Tbx5 |
T-box 5 |
621 |
0.7 |
chr13_6131432_6131800 | 23.07 |
Gm47548 |
predicted gene, 47548 |
57834 |
0.13 |
chr18_36017856_36019112 | 22.94 |
Nrg2 |
neuregulin 2 |
13457 |
0.16 |
chr11_117336202_117336679 | 22.81 |
Septin9 |
septin 9 |
4012 |
0.23 |
chr10_68158684_68159024 | 22.62 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
22228 |
0.23 |
chr5_66862241_66862546 | 22.58 |
Gm6517 |
predicted gene 6517 |
27973 |
0.15 |
chr4_63916675_63917037 | 22.42 |
Rpl17-ps4 |
ribosomal protein L17, pseudogene 4 |
20757 |
0.2 |
chr15_98180977_98181745 | 22.32 |
Olfr288 |
olfactory receptor 288 |
14084 |
0.1 |
chr7_96600681_96600832 | 22.24 |
Gm15414 |
predicted gene 15414 |
28313 |
0.2 |
chr14_70530107_70530260 | 22.15 |
Lgi3 |
leucine-rich repeat LGI family, member 3 |
502 |
0.65 |
chr11_79030690_79030970 | 22.06 |
Gm11201 |
predicted gene 11201 |
7233 |
0.19 |
chr8_62284797_62285008 | 21.78 |
Gm2961 |
predicted gene 2961 |
90690 |
0.09 |
chr9_13246797_13247848 | 21.77 |
Ccdc82 |
coiled-coil domain containing 82 |
340 |
0.82 |
chr9_100582882_100583033 | 21.74 |
Slc35g2 |
solute carrier family 35, member G2 |
11867 |
0.13 |
chr9_91385073_91385258 | 21.39 |
Zic4 |
zinc finger protein of the cerebellum 4 |
2755 |
0.17 |
chr9_35346391_35346736 | 21.31 |
2610105M22Rik |
RIKEN cDNA 2610105M22 gene |
16550 |
0.14 |
chr1_190979223_190979743 | 21.30 |
Vash2 |
vasohibin 2 |
187 |
0.9 |
chr7_6729309_6729829 | 21.28 |
Peg3 |
paternally expressed 3 |
850 |
0.28 |
chr10_76665127_76665305 | 21.20 |
Gm35608 |
predicted gene, 35608 |
19216 |
0.14 |
chr18_20938698_20939024 | 21.10 |
Rnf125 |
ring finger protein 125 |
5764 |
0.23 |
chr2_127521161_127522051 | 21.06 |
Kcnip3 |
Kv channel interacting protein 3, calsenilin |
236 |
0.88 |
chr14_71028386_71028538 | 21.06 |
Gm49289 |
predicted gene, 49289 |
58808 |
0.13 |
chr15_62462711_62463075 | 21.02 |
Gm41333 |
predicted gene, 41333 |
105082 |
0.08 |
chr7_30216721_30217157 | 20.94 |
Gm44600 |
predicted gene 44600 |
4201 |
0.08 |
chr7_89720202_89720395 | 20.86 |
Me3 |
malic enzyme 3, NADP(+)-dependent, mitochondrial |
16433 |
0.19 |
chr4_68906489_68906730 | 20.72 |
Brinp1 |
bone morphogenic protein/retinoic acid inducible neural specific 1 |
47788 |
0.2 |
chr18_64990264_64990536 | 20.69 |
Gm50368 |
predicted gene, 50368 |
10775 |
0.21 |
chr8_70120126_70120277 | 20.66 |
Ncan |
neurocan |
672 |
0.45 |
chr3_100480755_100481173 | 20.60 |
Tent5c |
terminal nucleotidyltransferase 5C |
8230 |
0.14 |
chr13_60225808_60226115 | 20.55 |
Gm5084 |
predicted gene 5084 |
14028 |
0.17 |
chr2_60978979_60979303 | 20.50 |
Gm13582 |
predicted gene 13582 |
3990 |
0.26 |
chr17_48005073_48005367 | 20.43 |
Gm14871 |
predicted gene 14871 |
1648 |
0.3 |
chr6_99042256_99042516 | 20.43 |
Foxp1 |
forkhead box P1 |
2056 |
0.41 |
chr13_45627470_45627741 | 20.40 |
Gmpr |
guanosine monophosphate reductase |
81452 |
0.1 |
chr8_12126295_12126640 | 20.33 |
A230072I06Rik |
RIKEN cDNA A230072I06 gene |
152352 |
0.03 |
chr2_66103742_66104045 | 20.18 |
Galnt3 |
polypeptide N-acetylgalactosaminyltransferase 3 |
1410 |
0.43 |
chr17_43451316_43451509 | 20.13 |
Gm25135 |
predicted gene, 25135 |
2843 |
0.27 |
chr7_128310169_128310374 | 20.08 |
Gm6916 |
predicted pseudogene 6916 |
4513 |
0.11 |
chr7_35344847_35345230 | 19.99 |
Rhpn2 |
rhophilin, Rho GTPase binding protein 2 |
10708 |
0.14 |
chr7_130977605_130978173 | 19.83 |
Htra1 |
HtrA serine peptidase 1 |
3781 |
0.24 |
chr16_42276867_42277080 | 19.82 |
Gap43 |
growth associated protein 43 |
901 |
0.65 |
chr8_23596316_23596734 | 19.80 |
Zmat4 |
zinc finger, matrin type 4 |
39494 |
0.19 |
chr9_107723394_107723636 | 19.63 |
Sema3f |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
13040 |
0.09 |
chr6_140368430_140368616 | 19.62 |
n-R5s168 |
nuclear encoded rRNA 5S 168 |
48893 |
0.11 |
chr6_89613728_89614091 | 19.56 |
Chchd6 |
coiled-coil-helix-coiled-coil-helix domain containing 6 |
18257 |
0.17 |
chr5_38158989_38159808 | 19.51 |
Nsg1 |
neuron specific gene family member 1 |
7 |
0.97 |
chr9_105764254_105764459 | 19.49 |
Gm38314 |
predicted gene, 38314 |
36571 |
0.14 |
chr15_90589691_90589847 | 19.47 |
Gm6746 |
predicted pseudogene 6746 |
28422 |
0.2 |
chr2_63273724_63274213 | 19.38 |
Kcnh7 |
potassium voltage-gated channel, subfamily H (eag-related), member 7 |
89681 |
0.09 |
chr19_53008463_53008657 | 19.33 |
Mir6407 |
microRNA 6407 |
2196 |
0.27 |
chr5_53123649_53123869 | 19.32 |
n-R5s171 |
nuclear encoded rRNA 5S 171 |
19401 |
0.17 |
chr6_29835800_29836301 | 19.31 |
Ahcyl2 |
S-adenosylhomocysteine hydrolase-like 2 |
17710 |
0.17 |
chr14_41185579_41185730 | 19.31 |
Sftpd |
surfactant associated protein D |
505 |
0.69 |
chr3_80802510_80803270 | 19.31 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
55 |
0.98 |
chr6_112809545_112809826 | 19.28 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
19774 |
0.21 |
chr16_11880607_11880758 | 19.26 |
Gm9961 |
predicted gene 9961 |
20681 |
0.2 |
chr1_85489813_85490173 | 19.25 |
AC147806.1 |
novel protein |
4851 |
0.14 |
chr7_134725562_134725843 | 19.23 |
Dock1 |
dedicator of cytokinesis 1 |
51753 |
0.15 |
chr5_99062665_99062987 | 19.17 |
Prkg2 |
protein kinase, cGMP-dependent, type II |
25475 |
0.2 |
chr3_129681848_129682139 | 19.17 |
Egf |
epidermal growth factor |
447 |
0.77 |
chr10_31068796_31068947 | 19.15 |
Gm30676 |
predicted gene, 30676 |
2627 |
0.34 |
chr9_62536098_62537614 | 19.15 |
Coro2b |
coronin, actin binding protein, 2B |
104 |
0.97 |
chr8_68416856_68417007 | 19.15 |
Gm15656 |
predicted gene 15656 |
40217 |
0.15 |
chr2_132427639_132427949 | 19.07 |
4921508D12Rik |
RIKEN cDNA 4921508D12 gene |
3053 |
0.25 |
chr15_95528851_95529002 | 19.04 |
Nell2 |
NEL-like 2 |
367 |
0.91 |
chr13_116309603_116310279 | 19.04 |
Isl1 |
ISL1 transcription factor, LIM/homeodomain |
252 |
0.94 |
chr12_84772482_84773778 | 19.04 |
Npc2 |
NPC intracellular cholesterol transporter 2 |
22 |
0.61 |
chr2_25178392_25178552 | 19.03 |
Nrarp |
Notch-regulated ankyrin repeat protein |
2286 |
0.11 |
chr15_30383087_30383401 | 18.96 |
Gm49283 |
predicted gene, 49283 |
45600 |
0.17 |
chr12_108371048_108371312 | 18.93 |
Eml1 |
echinoderm microtubule associated protein like 1 |
223 |
0.93 |
chr6_138077667_138077989 | 18.92 |
Slc15a5 |
solute carrier family 15, member 5 |
2088 |
0.43 |
chr6_142831365_142831548 | 18.81 |
Gm7457 |
predicted gene 7457 |
17071 |
0.17 |
chr8_73930397_73930548 | 18.80 |
Gm7948 |
predicted gene 7948 |
58779 |
0.16 |
chr16_21210400_21210955 | 18.77 |
Ephb3 |
Eph receptor B3 |
153 |
0.95 |
chr4_150730280_150730563 | 18.71 |
Gm16079 |
predicted gene 16079 |
51629 |
0.12 |
chr6_119409613_119410171 | 18.67 |
Adipor2 |
adiponectin receptor 2 |
7583 |
0.21 |
chr4_104463006_104463166 | 18.66 |
Dab1 |
disabled 1 |
48987 |
0.19 |
chr18_69624676_69624827 | 18.64 |
Tcf4 |
transcription factor 4 |
12307 |
0.27 |
chr16_18050407_18050558 | 18.54 |
Dgcr6 |
DiGeorge syndrome critical region gene 6 |
2378 |
0.21 |
chr2_158585022_158585287 | 18.50 |
Gm14204 |
predicted gene 14204 |
25436 |
0.1 |
chr16_72222039_72222224 | 18.43 |
8030451O07Rik |
RIKEN cDNA 8030451O07 gene |
12171 |
0.29 |
chr17_25463442_25463688 | 18.42 |
Tekt4 |
tektin 4 |
8025 |
0.11 |
chr19_40581054_40581215 | 18.38 |
Aldh18a1 |
aldehyde dehydrogenase 18 family, member A1 |
7235 |
0.12 |
chr8_94532048_94532199 | 18.38 |
Cpne2 |
copine II |
867 |
0.49 |
chr2_160327134_160327607 | 18.35 |
Gm826 |
predicted gene 826 |
124 |
0.98 |
chr1_85613380_85613547 | 18.33 |
Gm10552 |
predicted gene 10552 |
1567 |
0.22 |
chr8_76793939_76794245 | 18.32 |
Gm5353 |
predicted gene 5353 |
68956 |
0.12 |
chr13_108339834_108340203 | 18.30 |
Depdc1b |
DEP domain containing 1B |
13490 |
0.18 |
chr2_68394266_68394430 | 18.27 |
Stk39 |
serine/threonine kinase 39 |
7667 |
0.27 |
chr16_37893917_37894212 | 18.25 |
Gm15725 |
predicted gene 15725 |
11522 |
0.14 |
chr2_122708149_122708787 | 18.20 |
4930417H01Rik |
RIKEN cDNA 4930417H01 gene |
425 |
0.78 |
chr1_85162433_85162707 | 18.18 |
Gm6264 |
predicted gene 6264 |
1707 |
0.22 |
chr4_98348441_98348859 | 18.15 |
Gm12788 |
predicted gene 12788 |
3777 |
0.19 |
chr1_6733683_6734408 | 18.10 |
St18 |
suppression of tumorigenicity 18 |
825 |
0.73 |
chr3_105538840_105539458 | 18.07 |
Gm43847 |
predicted gene 43847 |
36242 |
0.16 |
chr2_32316251_32316402 | 18.05 |
Dnm1 |
dynamin 1 |
1005 |
0.28 |
chr8_27061810_27062236 | 18.00 |
Plpbp |
pyridoxal phosphate binding protein |
11249 |
0.1 |
chr10_52274470_52274678 | 17.99 |
Dcbld1 |
discoidin, CUB and LCCL domain containing 1 |
40937 |
0.11 |
chr3_87512360_87512527 | 17.95 |
Etv3 |
ets variant 3 |
12964 |
0.17 |
chr7_18950757_18950953 | 17.87 |
Nova2 |
NOVA alternative splicing regulator 2 |
24967 |
0.07 |
chr14_19977078_19977720 | 17.82 |
Gng2 |
guanine nucleotide binding protein (G protein), gamma 2 |
150 |
0.96 |
chr2_84887826_84888036 | 17.78 |
Rtn4rl2 |
reticulon 4 receptor-like 2 |
1221 |
0.36 |
chr1_16234941_16235276 | 17.76 |
Gm28095 |
predicted gene 28095 |
6602 |
0.19 |
chr13_56703202_56704180 | 17.75 |
Smad5 |
SMAD family member 5 |
23 |
0.98 |
chr9_58326496_58326804 | 17.74 |
Loxl1 |
lysyl oxidase-like 1 |
13464 |
0.15 |
chr7_130134941_130135269 | 17.70 |
Fgfr2 |
fibroblast growth factor receptor 2 |
32779 |
0.22 |
chr14_101653484_101654741 | 17.70 |
Uchl3 |
ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase) |
87 |
0.96 |
chr18_60652180_60652537 | 17.68 |
Synpo |
synaptopodin |
4039 |
0.21 |
chr17_12723948_12724782 | 17.67 |
Airn |
antisense Igf2r RNA |
16946 |
0.13 |
chr1_85095587_85095804 | 17.62 |
Gm10553 |
predicted gene 10553 |
3817 |
0.11 |
chr8_109464450_109464637 | 17.62 |
Pmfbp1 |
polyamine modulated factor 1 binding protein 1 |
29484 |
0.16 |
chr18_8054510_8054913 | 17.61 |
Gm4833 |
predicted gene 4833 |
3508 |
0.33 |
chr6_8105963_8106318 | 17.57 |
Col28a1 |
collagen, type XXVIII, alpha 1 |
26392 |
0.21 |
chr4_14621556_14621727 | 17.56 |
Slc26a7 |
solute carrier family 26, member 7 |
28 |
0.99 |
chr3_65541634_65541818 | 17.54 |
Tiparp |
TCDD-inducible poly(ADP-ribose) polymerase |
4314 |
0.15 |
chr7_72991374_72991525 | 17.54 |
Gm5335 |
predicted gene 5335 |
1296 |
0.54 |
chr9_41446382_41446785 | 17.52 |
Gm48739 |
predicted gene, 48739 |
27532 |
0.12 |
chr1_136142237_136142876 | 17.51 |
Kif21b |
kinesin family member 21B |
11102 |
0.11 |
chr15_59649484_59649654 | 17.51 |
Trib1 |
tribbles pseudokinase 1 |
916 |
0.61 |
chr4_116491126_116491280 | 17.50 |
Ipp |
IAP promoted placental gene |
16346 |
0.13 |
chr6_49989774_49989925 | 17.46 |
Gm3455 |
predicted gene 3455 |
61337 |
0.13 |
chr14_17923436_17923625 | 17.46 |
Thrb |
thyroid hormone receptor beta |
39291 |
0.18 |
chr1_33947103_33947453 | 17.46 |
Gm28631 |
predicted gene 28631 |
16407 |
0.12 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.3 | 41.2 | GO:0060486 | Clara cell differentiation(GO:0060486) |
8.6 | 51.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
7.7 | 23.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
7.5 | 30.0 | GO:0001880 | Mullerian duct regression(GO:0001880) |
6.7 | 20.1 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
6.7 | 20.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
6.6 | 19.7 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
6.1 | 18.4 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
5.9 | 17.8 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
5.9 | 17.6 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
5.8 | 5.8 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
5.6 | 16.8 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
5.6 | 16.7 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
5.3 | 15.8 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
5.1 | 10.2 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
5.0 | 14.9 | GO:0046098 | guanine metabolic process(GO:0046098) |
4.9 | 14.7 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
4.8 | 19.3 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
4.7 | 14.1 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
4.6 | 23.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
4.6 | 18.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
4.6 | 18.2 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
4.4 | 13.1 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
4.2 | 21.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
4.0 | 12.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
4.0 | 11.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
3.9 | 11.7 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
3.9 | 19.5 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
3.9 | 7.8 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
3.9 | 15.5 | GO:0001927 | exocyst assembly(GO:0001927) |
3.8 | 11.5 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
3.7 | 11.1 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
3.7 | 18.4 | GO:0019532 | oxalate transport(GO:0019532) |
3.6 | 25.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
3.6 | 14.2 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
3.5 | 7.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
3.5 | 10.5 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
3.4 | 6.9 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
3.4 | 10.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
3.3 | 10.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
3.3 | 13.1 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
3.2 | 9.7 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
3.2 | 12.8 | GO:0061743 | motor learning(GO:0061743) |
3.2 | 9.5 | GO:1904393 | positive regulation of postsynaptic membrane organization(GO:1901628) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
3.1 | 9.4 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
3.1 | 21.9 | GO:0016198 | axon choice point recognition(GO:0016198) |
3.1 | 6.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
3.1 | 6.2 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
3.0 | 9.1 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
3.0 | 9.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
3.0 | 12.0 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
2.9 | 8.6 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
2.8 | 5.6 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
2.8 | 14.1 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
2.8 | 14.0 | GO:0031034 | myosin filament assembly(GO:0031034) |
2.8 | 8.4 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
2.7 | 5.5 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
2.7 | 16.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
2.7 | 8.0 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
2.7 | 2.7 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
2.6 | 15.9 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
2.6 | 10.5 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
2.6 | 13.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
2.6 | 2.6 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
2.6 | 18.2 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
2.6 | 7.7 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
2.6 | 7.7 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
2.6 | 7.7 | GO:0070375 | ERK5 cascade(GO:0070375) |
2.6 | 12.8 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
2.5 | 10.1 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
2.5 | 7.6 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
2.5 | 20.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
2.5 | 5.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
2.5 | 7.5 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
2.5 | 12.5 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
2.5 | 7.5 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
2.5 | 7.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
2.5 | 5.0 | GO:0021586 | pons maturation(GO:0021586) |
2.5 | 9.9 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
2.4 | 2.4 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
2.4 | 36.4 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
2.4 | 7.2 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.4 | 9.6 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
2.4 | 7.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
2.4 | 9.6 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
2.4 | 4.8 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
2.4 | 7.1 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
2.4 | 7.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
2.3 | 7.0 | GO:0030035 | microspike assembly(GO:0030035) |
2.3 | 7.0 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) |
2.3 | 7.0 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.3 | 9.3 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
2.3 | 7.0 | GO:0007525 | somatic muscle development(GO:0007525) |
2.3 | 4.6 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
2.3 | 9.2 | GO:0030091 | protein repair(GO:0030091) |
2.3 | 6.9 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
2.3 | 9.2 | GO:0008228 | opsonization(GO:0008228) |
2.3 | 13.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
2.2 | 2.2 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
2.2 | 6.7 | GO:1901656 | glycoside transport(GO:1901656) |
2.2 | 6.7 | GO:0071895 | odontoblast differentiation(GO:0071895) |
2.2 | 4.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
2.2 | 8.7 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
2.1 | 25.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
2.1 | 12.7 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
2.1 | 6.4 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
2.1 | 4.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
2.1 | 4.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
2.1 | 10.5 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
2.1 | 6.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
2.1 | 6.3 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
2.1 | 29.3 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
2.1 | 8.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
2.0 | 28.1 | GO:0007413 | axonal fasciculation(GO:0007413) |
2.0 | 4.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
2.0 | 6.0 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
2.0 | 14.0 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
2.0 | 5.9 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
1.9 | 3.9 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
1.9 | 3.8 | GO:0090135 | actin filament branching(GO:0090135) |
1.9 | 3.8 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
1.9 | 9.4 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.9 | 5.7 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
1.9 | 5.6 | GO:0031296 | B cell costimulation(GO:0031296) |
1.9 | 13.1 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
1.9 | 11.2 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
1.9 | 7.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
1.8 | 7.4 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.8 | 7.3 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
1.8 | 18.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.8 | 3.6 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
1.8 | 5.4 | GO:0006868 | glutamine transport(GO:0006868) |
1.8 | 8.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.8 | 3.6 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
1.8 | 5.3 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
1.8 | 3.5 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.8 | 5.3 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
1.8 | 1.8 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
1.8 | 7.0 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.8 | 8.8 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
1.7 | 3.5 | GO:0035564 | regulation of kidney size(GO:0035564) |
1.7 | 12.0 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.7 | 5.1 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
1.7 | 6.8 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.7 | 3.4 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
1.7 | 8.5 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
1.7 | 22.0 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
1.7 | 8.5 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
1.7 | 5.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
1.7 | 5.0 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.7 | 15.0 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
1.7 | 10.0 | GO:0006477 | protein sulfation(GO:0006477) |
1.7 | 5.0 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
1.6 | 4.9 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
1.6 | 1.6 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
1.6 | 8.1 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
1.6 | 3.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
1.6 | 1.6 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
1.6 | 1.6 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
1.6 | 4.7 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.6 | 17.3 | GO:0071625 | vocalization behavior(GO:0071625) |
1.6 | 3.1 | GO:1901631 | positive regulation of presynaptic membrane organization(GO:1901631) |
1.6 | 3.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
1.5 | 1.5 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
1.5 | 9.3 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
1.5 | 4.6 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
1.5 | 12.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.5 | 4.6 | GO:0030242 | pexophagy(GO:0030242) |
1.5 | 7.6 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
1.5 | 4.6 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
1.5 | 6.0 | GO:0016139 | glycoside catabolic process(GO:0016139) |
1.5 | 4.5 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
1.5 | 6.0 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
1.5 | 7.4 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
1.5 | 1.5 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
1.5 | 10.2 | GO:0060346 | bone trabecula formation(GO:0060346) |
1.5 | 4.4 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.5 | 10.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
1.4 | 14.3 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
1.4 | 2.8 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.4 | 7.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.4 | 1.4 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
1.4 | 5.6 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
1.4 | 4.2 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.4 | 4.2 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
1.4 | 14.0 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.4 | 12.6 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
1.4 | 5.6 | GO:0006566 | threonine metabolic process(GO:0006566) |
1.4 | 4.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
1.4 | 6.9 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.4 | 2.7 | GO:0060596 | mammary placode formation(GO:0060596) |
1.4 | 2.7 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
1.3 | 2.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.3 | 4.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
1.3 | 2.7 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
1.3 | 20.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.3 | 5.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
1.3 | 1.3 | GO:0035995 | detection of muscle stretch(GO:0035995) |
1.3 | 4.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.3 | 4.0 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.3 | 13.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
1.3 | 10.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
1.3 | 2.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.3 | 3.9 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
1.3 | 5.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.3 | 3.8 | GO:0015755 | fructose transport(GO:0015755) |
1.3 | 3.8 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
1.3 | 5.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.3 | 5.1 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.3 | 3.8 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
1.3 | 5.1 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
1.3 | 1.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
1.3 | 2.5 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) sinoatrial node cell development(GO:0060931) |
1.3 | 6.3 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.3 | 2.5 | GO:0030576 | Cajal body organization(GO:0030576) |
1.3 | 2.5 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
1.2 | 2.5 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
1.2 | 2.5 | GO:0003186 | tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
1.2 | 5.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
1.2 | 1.2 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.2 | 3.7 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.2 | 5.0 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.2 | 1.2 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
1.2 | 1.2 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
1.2 | 3.7 | GO:0097503 | sialylation(GO:0097503) |
1.2 | 7.3 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
1.2 | 7.3 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
1.2 | 6.0 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
1.2 | 6.0 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
1.2 | 6.0 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
1.2 | 3.6 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
1.2 | 1.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.2 | 23.8 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
1.2 | 2.4 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.2 | 8.3 | GO:0099515 | actin filament-based transport(GO:0099515) |
1.2 | 5.9 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
1.2 | 7.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
1.2 | 5.8 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
1.2 | 3.5 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.2 | 19.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
1.2 | 5.8 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
1.1 | 4.6 | GO:0007412 | axon target recognition(GO:0007412) |
1.1 | 5.7 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
1.1 | 5.7 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
1.1 | 8.0 | GO:0060613 | fat pad development(GO:0060613) |
1.1 | 1.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.1 | 5.7 | GO:0061042 | vascular wound healing(GO:0061042) |
1.1 | 2.3 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
1.1 | 4.5 | GO:0060033 | anatomical structure regression(GO:0060033) |
1.1 | 3.4 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
1.1 | 2.2 | GO:0010046 | response to mycotoxin(GO:0010046) |
1.1 | 4.5 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
1.1 | 3.3 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
1.1 | 3.3 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
1.1 | 4.4 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
1.1 | 1.1 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
1.1 | 5.5 | GO:0070842 | aggresome assembly(GO:0070842) |
1.1 | 3.3 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
1.1 | 7.7 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
1.1 | 2.2 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
1.1 | 2.2 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.1 | 3.3 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
1.1 | 1.1 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
1.1 | 2.2 | GO:0031033 | myosin filament organization(GO:0031033) |
1.1 | 8.7 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
1.1 | 1.1 | GO:0072240 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
1.1 | 6.5 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
1.1 | 6.5 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
1.1 | 3.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
1.1 | 3.2 | GO:0060592 | mammary gland formation(GO:0060592) |
1.1 | 2.2 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
1.1 | 2.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
1.1 | 3.2 | GO:0006116 | NADH oxidation(GO:0006116) |
1.1 | 2.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
1.1 | 4.3 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
1.1 | 5.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
1.1 | 5.3 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
1.1 | 3.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
1.1 | 11.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
1.1 | 1.1 | GO:0002884 | regulation of type IV hypersensitivity(GO:0001807) negative regulation of hypersensitivity(GO:0002884) |
1.0 | 7.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
1.0 | 8.3 | GO:0030575 | nuclear body organization(GO:0030575) |
1.0 | 2.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
1.0 | 10.4 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
1.0 | 2.1 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
1.0 | 3.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
1.0 | 3.1 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
1.0 | 3.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
1.0 | 5.2 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
1.0 | 5.2 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
1.0 | 1.0 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.0 | 3.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
1.0 | 1.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
1.0 | 3.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
1.0 | 4.1 | GO:0072567 | chemokine (C-X-C motif) ligand 2 production(GO:0072567) |
1.0 | 3.0 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
1.0 | 7.1 | GO:0006108 | malate metabolic process(GO:0006108) |
1.0 | 2.0 | GO:2000858 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
1.0 | 2.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.0 | 1.0 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
1.0 | 3.0 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
1.0 | 2.0 | GO:0035482 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
1.0 | 2.0 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
1.0 | 3.9 | GO:0014028 | notochord formation(GO:0014028) |
1.0 | 1.0 | GO:0035787 | cell migration involved in kidney development(GO:0035787) |
1.0 | 1.9 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
1.0 | 2.9 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
1.0 | 1.9 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
1.0 | 3.9 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
1.0 | 3.8 | GO:0060426 | lung vasculature development(GO:0060426) |
1.0 | 4.8 | GO:0060914 | heart formation(GO:0060914) |
1.0 | 1.9 | GO:0051665 | membrane raft localization(GO:0051665) |
1.0 | 1.0 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.9 | 1.9 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.9 | 4.7 | GO:0051639 | actin filament network formation(GO:0051639) |
0.9 | 1.9 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.9 | 1.9 | GO:0021550 | medulla oblongata development(GO:0021550) |
0.9 | 3.7 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.9 | 6.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.9 | 2.8 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.9 | 2.7 | GO:0032439 | endosome localization(GO:0032439) |
0.9 | 0.9 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.9 | 2.7 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.9 | 3.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.9 | 2.7 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.9 | 0.9 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.9 | 5.4 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.9 | 2.7 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.9 | 3.6 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.9 | 6.2 | GO:0032328 | alanine transport(GO:0032328) |
0.9 | 0.9 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.9 | 1.8 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.9 | 0.9 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.9 | 7.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.9 | 0.9 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.9 | 1.7 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.9 | 2.6 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.9 | 1.7 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.9 | 4.3 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.9 | 6.9 | GO:0060717 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.9 | 5.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.9 | 2.6 | GO:0019086 | late viral transcription(GO:0019086) |
0.9 | 0.9 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.9 | 3.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.9 | 0.9 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.9 | 5.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.9 | 5.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.9 | 1.7 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.9 | 2.6 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.9 | 2.6 | GO:0015888 | thiamine transport(GO:0015888) |
0.8 | 3.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.8 | 4.2 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.8 | 2.5 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.8 | 2.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.8 | 5.9 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.8 | 0.8 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.8 | 0.8 | GO:0003163 | sinoatrial node development(GO:0003163) |
0.8 | 1.7 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.8 | 2.5 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.8 | 0.8 | GO:0015744 | succinate transport(GO:0015744) |
0.8 | 1.7 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.8 | 2.5 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.8 | 6.6 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.8 | 5.8 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.8 | 2.5 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.8 | 1.7 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.8 | 4.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.8 | 1.6 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.8 | 4.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.8 | 3.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.8 | 4.1 | GO:0043301 | negative regulation of leukocyte degranulation(GO:0043301) |
0.8 | 1.6 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.8 | 1.6 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.8 | 0.8 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.8 | 1.6 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.8 | 5.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.8 | 2.4 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.8 | 7.2 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.8 | 5.6 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.8 | 2.4 | GO:1902896 | terminal web assembly(GO:1902896) |
0.8 | 0.8 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.8 | 1.6 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.8 | 1.6 | GO:0010288 | response to lead ion(GO:0010288) |
0.8 | 2.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.8 | 3.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.8 | 5.4 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.8 | 2.3 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.8 | 6.8 | GO:0070269 | pyroptosis(GO:0070269) |
0.8 | 0.8 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.8 | 2.3 | GO:0019230 | proprioception(GO:0019230) |
0.8 | 4.5 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.8 | 1.5 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.8 | 1.5 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.7 | 6.7 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.7 | 0.7 | GO:1904478 | regulation of intestinal absorption(GO:1904478) |
0.7 | 8.0 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.7 | 0.7 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.7 | 3.6 | GO:0097264 | self proteolysis(GO:0097264) |
0.7 | 2.9 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.7 | 0.7 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.7 | 3.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.7 | 0.7 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.7 | 4.3 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.7 | 0.7 | GO:0014870 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.7 | 5.7 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.7 | 2.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.7 | 2.8 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.7 | 2.8 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.7 | 0.7 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.7 | 12.0 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.7 | 0.7 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.7 | 0.7 | GO:0010882 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.7 | 1.4 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.7 | 2.8 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.7 | 27.3 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.7 | 4.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.7 | 2.8 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.7 | 2.1 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.7 | 0.7 | GO:0071727 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.7 | 3.4 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.7 | 3.4 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.7 | 3.4 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.7 | 4.7 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.7 | 19.5 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.7 | 0.7 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.7 | 0.7 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.7 | 4.7 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.7 | 1.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.7 | 1.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.7 | 10.6 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.7 | 3.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.7 | 13.8 | GO:0048665 | neuron fate specification(GO:0048665) |
0.7 | 2.0 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.7 | 1.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.7 | 0.7 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.7 | 3.3 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.7 | 2.6 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.6 | 1.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.6 | 3.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.6 | 0.6 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.6 | 1.3 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.6 | 1.9 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.6 | 0.6 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.6 | 1.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.6 | 10.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.6 | 2.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.6 | 2.5 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.6 | 1.9 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.6 | 3.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.6 | 1.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.6 | 0.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.6 | 1.3 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.6 | 1.9 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.6 | 2.5 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.6 | 2.5 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.6 | 3.1 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.6 | 2.5 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.6 | 1.9 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.6 | 5.6 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.6 | 1.2 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.6 | 0.6 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.6 | 5.6 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.6 | 6.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.6 | 3.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.6 | 1.8 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.6 | 1.8 | GO:0006562 | proline catabolic process(GO:0006562) |
0.6 | 1.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.6 | 2.4 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.6 | 2.4 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.6 | 0.6 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.6 | 2.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.6 | 2.4 | GO:0003179 | heart valve morphogenesis(GO:0003179) |
0.6 | 0.6 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.6 | 1.8 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.6 | 3.0 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.6 | 4.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.6 | 0.6 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.6 | 1.8 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.6 | 6.6 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.6 | 4.2 | GO:0015816 | glycine transport(GO:0015816) |
0.6 | 3.0 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.6 | 1.8 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.6 | 2.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.6 | 1.8 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.6 | 5.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.6 | 5.9 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.6 | 1.8 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.6 | 0.6 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.6 | 1.2 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.6 | 1.7 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.6 | 2.3 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.6 | 1.7 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.6 | 3.5 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.6 | 2.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.6 | 2.9 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.6 | 1.1 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.6 | 1.1 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.6 | 0.6 | GO:0060157 | urinary bladder development(GO:0060157) |
0.6 | 1.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.6 | 1.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.6 | 1.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.6 | 9.7 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.6 | 2.3 | GO:0042737 | drug catabolic process(GO:0042737) |
0.6 | 1.7 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.6 | 1.7 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.6 | 2.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.6 | 1.7 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.6 | 2.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.6 | 1.7 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.6 | 1.7 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.6 | 2.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.6 | 1.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.6 | 0.6 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.6 | 0.6 | GO:0010159 | specification of organ position(GO:0010159) |
0.6 | 2.2 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.6 | 1.1 | GO:2000551 | regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.6 | 1.1 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.6 | 0.6 | GO:0060166 | olfactory pit development(GO:0060166) |
0.6 | 7.2 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.6 | 2.8 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.5 | 1.6 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.5 | 1.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.5 | 0.5 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.5 | 1.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.5 | 2.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.5 | 1.6 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.5 | 0.5 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.5 | 2.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.5 | 1.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.5 | 1.6 | GO:0015884 | folic acid transport(GO:0015884) |
0.5 | 0.5 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.5 | 2.1 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.5 | 2.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.5 | 2.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.5 | 2.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.5 | 1.6 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.5 | 1.6 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.5 | 2.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.5 | 3.7 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.5 | 1.1 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.5 | 5.8 | GO:0003334 | keratinocyte development(GO:0003334) |
0.5 | 5.2 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.5 | 1.0 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.5 | 3.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.5 | 3.1 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.5 | 1.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.5 | 2.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.5 | 0.5 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.5 | 5.7 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.5 | 1.5 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.5 | 3.1 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.5 | 1.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.5 | 1.5 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.5 | 2.0 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.5 | 0.5 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.5 | 11.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.5 | 6.1 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.5 | 1.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.5 | 2.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.5 | 6.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.5 | 1.0 | GO:0090399 | replicative senescence(GO:0090399) |
0.5 | 1.5 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.5 | 1.5 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.5 | 8.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.5 | 2.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.5 | 4.5 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.5 | 1.0 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.5 | 0.5 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.5 | 0.5 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.5 | 3.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.5 | 1.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.5 | 1.0 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.5 | 14.9 | GO:0032760 | positive regulation of tumor necrosis factor production(GO:0032760) |
0.5 | 3.0 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.5 | 0.5 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.5 | 1.0 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.5 | 2.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.5 | 1.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.5 | 2.0 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.5 | 3.9 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.5 | 6.3 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.5 | 0.5 | GO:0021940 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.5 | 1.5 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.5 | 1.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.5 | 2.4 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
0.5 | 6.8 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.5 | 2.9 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.5 | 1.9 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.5 | 1.9 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.5 | 2.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.5 | 3.4 | GO:0051923 | sulfation(GO:0051923) |
0.5 | 1.4 | GO:0050955 | thermoception(GO:0050955) |
0.5 | 2.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.5 | 1.0 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.5 | 1.4 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.5 | 1.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.5 | 1.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.5 | 2.4 | GO:0032049 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
0.5 | 0.9 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.5 | 5.6 | GO:0003341 | cilium movement(GO:0003341) |
0.5 | 2.8 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.5 | 1.9 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.5 | 2.3 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.5 | 1.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.5 | 0.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.5 | 1.4 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.5 | 0.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.5 | 2.8 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.5 | 0.5 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.5 | 0.9 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.5 | 1.8 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.5 | 1.8 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.5 | 1.4 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.5 | 7.3 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.5 | 3.6 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.5 | 0.9 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.5 | 1.4 | GO:0051182 | coenzyme transport(GO:0051182) |
0.5 | 6.8 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.4 | 11.7 | GO:0015914 | phospholipid transport(GO:0015914) |
0.4 | 0.4 | GO:1902071 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.4 | 0.9 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.4 | 1.3 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.4 | 0.9 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.4 | 0.4 | GO:0072179 | nephric duct formation(GO:0072179) |
0.4 | 0.4 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.4 | 1.3 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.4 | 1.3 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.4 | 1.3 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.4 | 0.9 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.4 | 1.3 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.4 | 2.2 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.4 | 2.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.4 | 0.9 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.4 | 3.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.4 | 1.7 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.4 | 0.9 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.4 | 2.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.4 | 0.4 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.4 | 1.3 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.4 | 0.4 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.4 | 3.9 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.4 | 1.3 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
0.4 | 1.3 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.4 | 0.4 | GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) |
0.4 | 3.4 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.4 | 3.0 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.4 | 1.7 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.4 | 2.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.4 | 15.3 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.4 | 0.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.4 | 3.4 | GO:0031100 | organ regeneration(GO:0031100) |
0.4 | 1.7 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.4 | 1.3 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.4 | 0.4 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.4 | 1.3 | GO:0099622 | cardiac muscle cell membrane repolarization(GO:0099622) |
0.4 | 0.8 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.4 | 4.2 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.4 | 4.2 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.4 | 1.3 | GO:0008355 | olfactory learning(GO:0008355) |
0.4 | 0.4 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.4 | 1.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.4 | 1.3 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.4 | 1.3 | GO:0060023 | soft palate development(GO:0060023) |
0.4 | 0.8 | GO:0042851 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.4 | 2.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.4 | 14.1 | GO:0070206 | protein trimerization(GO:0070206) |
0.4 | 1.7 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.4 | 4.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.4 | 1.2 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.4 | 3.3 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.4 | 0.8 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.4 | 0.8 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.4 | 2.8 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) establishment of mitochondrion localization(GO:0051654) |
0.4 | 0.4 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.4 | 2.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.4 | 0.8 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.4 | 1.2 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.4 | 4.8 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.4 | 1.2 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.4 | 2.8 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.4 | 1.2 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.4 | 5.2 | GO:0031114 | regulation of microtubule depolymerization(GO:0031114) |
0.4 | 2.0 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.4 | 1.6 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.4 | 0.4 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.4 | 1.6 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.4 | 8.7 | GO:0006063 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
0.4 | 1.2 | GO:0044838 | cell quiescence(GO:0044838) |
0.4 | 0.4 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.4 | 11.4 | GO:0001936 | regulation of endothelial cell proliferation(GO:0001936) |
0.4 | 2.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.4 | 0.8 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.4 | 1.2 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.4 | 2.7 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.4 | 0.4 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.4 | 0.8 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.4 | 0.8 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.4 | 1.9 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.4 | 1.9 | GO:0090383 | phagosome acidification(GO:0090383) |
0.4 | 1.9 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.4 | 2.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.4 | 1.5 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.4 | 0.8 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.4 | 1.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.4 | 0.8 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
0.4 | 0.4 | GO:0048664 | neuron fate determination(GO:0048664) |
0.4 | 2.2 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.4 | 0.4 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.4 | 0.4 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.4 | 1.5 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.4 | 0.7 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.4 | 0.7 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.4 | 1.1 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.4 | 0.4 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) |
0.4 | 1.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.4 | 0.7 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.4 | 0.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.4 | 0.4 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.4 | 8.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.4 | 1.1 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.4 | 2.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.4 | 1.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.4 | 2.9 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.4 | 0.4 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.4 | 1.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.4 | 0.7 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.4 | 0.7 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.4 | 1.1 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.4 | 2.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.4 | 8.1 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.4 | 0.4 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.4 | 1.1 | GO:0018158 | protein oxidation(GO:0018158) |
0.4 | 3.2 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.3 | 0.7 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.3 | 2.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.3 | 0.7 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.3 | 0.3 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.3 | 1.7 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.3 | 0.7 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.3 | 0.7 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.3 | 0.7 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.3 | 0.3 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.3 | 0.7 | GO:0090071 | regulation of ribosome biogenesis(GO:0090069) negative regulation of ribosome biogenesis(GO:0090071) |
0.3 | 0.7 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 0.3 | GO:0002339 | B cell selection(GO:0002339) |
0.3 | 0.7 | GO:0031620 | regulation of fever generation(GO:0031620) |
0.3 | 0.3 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.3 | 0.7 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.3 | 0.3 | GO:0035412 | regulation of catenin import into nucleus(GO:0035412) positive regulation of catenin import into nucleus(GO:0035413) |
0.3 | 1.4 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.3 | 3.4 | GO:0060420 | regulation of heart growth(GO:0060420) |
0.3 | 0.3 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.3 | 5.1 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.3 | 0.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.3 | 1.0 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.3 | 8.4 | GO:0010761 | fibroblast migration(GO:0010761) |
0.3 | 0.3 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.3 | 0.7 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.3 | 0.7 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.3 | 1.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.3 | 0.7 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.3 | 1.0 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.3 | 1.3 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.3 | 1.6 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.3 | 0.7 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.3 | 1.6 | GO:0007320 | insemination(GO:0007320) |
0.3 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 0.7 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
0.3 | 6.9 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.3 | 3.3 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.3 | 1.3 | GO:0046836 | glycolipid transport(GO:0046836) |
0.3 | 0.7 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.3 | 1.9 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.3 | 1.0 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 | 0.3 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.3 | 3.8 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.3 | 0.6 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.3 | 0.3 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.3 | 0.6 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.3 | 1.3 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.3 | 2.5 | GO:1904407 | positive regulation of nitric oxide biosynthetic process(GO:0045429) positive regulation of nitric oxide metabolic process(GO:1904407) |
0.3 | 0.9 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.3 | 0.6 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.3 | 0.9 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.3 | 1.5 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.3 | 1.2 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.3 | 4.0 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.3 | 0.3 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.3 | 15.6 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.3 | 0.6 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.3 | 3.7 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.3 | 1.5 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.3 | 0.6 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.3 | 0.6 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.3 | 0.9 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.3 | 6.0 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.3 | 0.9 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.3 | 1.8 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.3 | 1.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.3 | 0.9 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.3 | 0.3 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) positive regulation of neuron maturation(GO:0014042) |
0.3 | 1.5 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.3 | 2.6 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.3 | 1.2 | GO:0007614 | short-term memory(GO:0007614) |
0.3 | 0.3 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.3 | 2.9 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.3 | 0.3 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.3 | 1.4 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.3 | 0.3 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.3 | 0.3 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.3 | 0.6 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.3 | 2.0 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.3 | 0.9 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 0.3 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.3 | 0.3 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.3 | 1.1 | GO:0009624 | response to nematode(GO:0009624) |
0.3 | 2.0 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.3 | 2.0 | GO:1990089 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
0.3 | 0.3 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.3 | 2.5 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.3 | 0.3 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.3 | 0.6 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.3 | 1.4 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.3 | 1.4 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.3 | 0.8 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.3 | 0.6 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.3 | 0.8 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.3 | 0.3 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.3 | 1.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 0.3 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.3 | 1.9 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.3 | 0.5 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.3 | 0.5 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.3 | 0.3 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.3 | 1.9 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.3 | 0.3 | GO:0061323 | cell proliferation involved in heart morphogenesis(GO:0061323) |
0.3 | 5.1 | GO:0048286 | lung alveolus development(GO:0048286) |
0.3 | 0.5 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.3 | 0.5 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.3 | 0.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.3 | 0.5 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.3 | 1.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 0.8 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.3 | 4.2 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.3 | 0.8 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.3 | 0.8 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.3 | 3.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 0.5 | GO:0060343 | trabecula formation(GO:0060343) |
0.3 | 3.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.3 | 4.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.3 | 1.8 | GO:0034033 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.3 | 1.5 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.3 | 0.3 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.3 | 1.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.3 | 0.5 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.3 | 0.3 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.3 | 2.3 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.2 | 0.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.2 | 1.5 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.2 | 0.5 | GO:0035425 | autocrine signaling(GO:0035425) |
0.2 | 0.7 | GO:0071435 | potassium ion export(GO:0071435) |
0.2 | 4.6 | GO:0050679 | positive regulation of epithelial cell proliferation(GO:0050679) |
0.2 | 0.2 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.2 | 2.0 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.2 | 1.0 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.2 | 0.2 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 0.5 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.2 | 0.2 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.2 | 1.0 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.2 | 0.2 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.2 | 0.7 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.2 | 0.7 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 1.2 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.2 | 0.2 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.2 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 0.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.2 | 1.4 | GO:0035878 | nail development(GO:0035878) |
0.2 | 0.2 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.2 | 0.5 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.2 | 0.5 | GO:0042160 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.2 | 0.5 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.2 | 0.9 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 1.8 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.2 | 0.9 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.2 | 0.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.2 | 0.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 0.7 | GO:1900424 | regulation of defense response to bacterium(GO:1900424) |
0.2 | 0.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 0.9 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 6.0 | GO:0031424 | keratinization(GO:0031424) |
0.2 | 0.2 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.2 | 0.9 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 0.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 1.3 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.2 | 2.0 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.2 | 5.6 | GO:0006284 | base-excision repair(GO:0006284) |
0.2 | 0.2 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.2 | 0.2 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
0.2 | 0.9 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 0.2 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.2 | 3.7 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.2 | 0.2 | GO:0031272 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) |
0.2 | 0.4 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.2 | 0.6 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.2 | 0.6 | GO:0061083 | regulation of protein refolding(GO:0061083) |
0.2 | 1.1 | GO:0002063 | chondrocyte development(GO:0002063) |
0.2 | 0.9 | GO:0001553 | luteinization(GO:0001553) |
0.2 | 0.2 | GO:0000436 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) |
0.2 | 9.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 0.4 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 0.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 1.3 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.2 | 0.6 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 1.0 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.2 | 2.9 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 | 0.8 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.2 | 0.2 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.2 | 0.6 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.2 | 0.4 | GO:1900117 | regulation of execution phase of apoptosis(GO:1900117) |
0.2 | 0.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.2 | 0.8 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 0.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 1.8 | GO:0007520 | myoblast fusion(GO:0007520) |
0.2 | 1.0 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.2 | 0.8 | GO:0002347 | response to tumor cell(GO:0002347) |
0.2 | 0.2 | GO:0009838 | abscission(GO:0009838) |
0.2 | 6.8 | GO:0001764 | neuron migration(GO:0001764) |
0.2 | 2.0 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.2 | 0.4 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.2 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.2 | 0.4 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 1.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 0.2 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.2 | 0.4 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.2 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 0.6 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 1.2 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 2.1 | GO:0032094 | response to food(GO:0032094) |
0.2 | 0.2 | GO:0098856 | intestinal lipid absorption(GO:0098856) |
0.2 | 1.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 1.7 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.2 | 0.8 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.2 | 3.2 | GO:0019228 | neuronal action potential(GO:0019228) |
0.2 | 0.9 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 2.0 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 1.1 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.2 | 0.2 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.2 | 0.7 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.2 | 2.4 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.2 | 0.4 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.2 | 2.2 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.2 | 7.0 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.2 | 0.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 0.2 | GO:0033058 | directional locomotion(GO:0033058) |
0.2 | 1.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 0.2 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 0.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 2.1 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.2 | 0.7 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.2 | 0.4 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.2 | 3.0 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.2 | 0.7 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.2 | 0.9 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.2 | 0.5 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 0.2 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.2 | 0.2 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
0.2 | 0.2 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.2 | 0.3 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 2.7 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 0.5 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 0.2 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.2 | 0.2 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.2 | 0.3 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.2 | 0.3 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.2 | 0.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 0.7 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.2 | 0.7 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.2 | 0.2 | GO:1900164 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.2 | 0.2 | GO:0003309 | type B pancreatic cell differentiation(GO:0003309) |
0.2 | 0.2 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.2 | 1.6 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.2 | 0.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 1.0 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 0.5 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.2 | 0.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.2 | 0.5 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.2 | 0.5 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.2 | 0.6 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.2 | 0.2 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
0.2 | 0.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.2 | 0.2 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.2 | 0.3 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.2 | 0.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 0.9 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.2 | 0.2 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.2 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.3 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.1 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 2.2 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.1 | 3.5 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.6 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 0.6 | GO:0002585 | positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) |
0.1 | 0.3 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 1.0 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.1 | GO:0051198 | negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.1 | 0.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.4 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.4 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 3.4 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.3 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.1 | GO:0072189 | ureter development(GO:0072189) |
0.1 | 0.5 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 1.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.3 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 1.9 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.5 | GO:0032816 | positive regulation of natural killer cell activation(GO:0032816) |
0.1 | 0.4 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.1 | 0.3 | GO:0030239 | myofibril assembly(GO:0030239) |
0.1 | 1.0 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.4 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.1 | GO:0021546 | rhombomere development(GO:0021546) |
0.1 | 0.6 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 1.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.1 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.4 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.1 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 3.0 | GO:0007613 | memory(GO:0007613) |
0.1 | 0.5 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.1 | GO:0072160 | nephron tubule epithelial cell differentiation(GO:0072160) |
0.1 | 1.3 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.1 | 0.4 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.1 | GO:0046005 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.1 | 0.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.2 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.1 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 | 0.2 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.1 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.1 | 0.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.3 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.6 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 0.6 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.2 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.1 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.1 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.6 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 2.2 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 0.8 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.1 | 0.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.8 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.1 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.1 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.8 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 2.6 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.1 | 1.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.2 | GO:1904705 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.1 | 0.2 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.2 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.3 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.1 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 0.6 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.8 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.4 | GO:1904382 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.1 | 0.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.2 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 0.4 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.2 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.1 | GO:1903055 | positive regulation of extracellular matrix organization(GO:1903055) |
0.1 | 0.1 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.1 | 0.1 | GO:0034238 | macrophage fusion(GO:0034238) |
0.1 | 0.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 0.1 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.1 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.3 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.2 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.2 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.3 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 4.4 | GO:0035195 | gene silencing by miRNA(GO:0035195) |
0.1 | 2.4 | GO:0042633 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.1 | 0.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.5 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.3 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.1 | 0.2 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.1 | 0.1 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.1 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.1 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.3 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.1 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 2.8 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.1 | 0.1 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.1 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.1 | 0.4 | GO:1990173 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.1 | 0.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.1 | 0.4 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.1 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.1 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 0.5 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.1 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 0.6 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.1 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.1 | 0.2 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.3 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.1 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.1 | 0.2 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.1 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) |
0.1 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.1 | GO:0072074 | kidney mesenchyme development(GO:0072074) |
0.1 | 0.2 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.1 | 0.4 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 0.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.2 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.1 | GO:0032633 | interleukin-4 production(GO:0032633) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.2 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.0 | GO:0003230 | cardiac atrium development(GO:0003230) |
0.0 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.0 | 0.0 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.0 | 0.0 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.0 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.0 | 0.2 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.0 | 0.1 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 0.4 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.0 | 0.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.3 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 0.0 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.0 | 0.1 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.1 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.5 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.0 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.1 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) |
0.0 | 0.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.0 | 0.0 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.0 | 0.5 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.0 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.0 | GO:0007567 | parturition(GO:0007567) |
0.0 | 1.0 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.1 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.0 | 0.0 | GO:1902714 | regulation of interferon-gamma secretion(GO:1902713) negative regulation of interferon-gamma secretion(GO:1902714) |
0.0 | 0.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 0.0 | GO:0001759 | organ induction(GO:0001759) |
0.0 | 0.0 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.0 | 0.0 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.0 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.1 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.1 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.0 | 0.1 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.0 | 0.1 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.0 | 0.0 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.0 | GO:0009217 | purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
0.0 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.7 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.0 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.3 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.0 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.0 | 0.0 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.0 | 0.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.2 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.0 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.0 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.0 | GO:0010460 | positive regulation of heart rate(GO:0010460) |
0.0 | 0.1 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.0 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 0.0 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.0 | 0.2 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.5 | GO:0007041 | lysosomal transport(GO:0007041) |
0.0 | 0.0 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.0 | 0.0 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.0 | 0.0 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.0 | 0.0 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.0 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.6 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.3 | GO:0048754 | branching morphogenesis of an epithelial tube(GO:0048754) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.0 | GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) |
0.0 | 0.1 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.0 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.0 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.1 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 0.0 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.0 | 0.0 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.6 | 16.8 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
5.1 | 20.5 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
4.9 | 14.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
4.3 | 12.8 | GO:0031143 | pseudopodium(GO:0031143) |
4.2 | 29.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
4.2 | 12.6 | GO:0043511 | inhibin complex(GO:0043511) |
3.7 | 11.1 | GO:0097449 | astrocyte projection(GO:0097449) |
3.2 | 19.0 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
3.1 | 12.5 | GO:0045298 | tubulin complex(GO:0045298) |
3.0 | 27.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
3.0 | 9.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
2.8 | 8.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
2.8 | 38.8 | GO:0031527 | filopodium membrane(GO:0031527) |
2.8 | 11.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
2.6 | 15.8 | GO:0005915 | zonula adherens(GO:0005915) |
2.6 | 7.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
2.6 | 7.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
2.5 | 15.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
2.5 | 7.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
2.5 | 7.4 | GO:1990812 | growth cone filopodium(GO:1990812) |
2.4 | 2.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
2.3 | 9.4 | GO:1990357 | terminal web(GO:1990357) |
2.3 | 7.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
2.3 | 32.0 | GO:0032279 | asymmetric synapse(GO:0032279) |
2.2 | 9.0 | GO:0000322 | storage vacuole(GO:0000322) |
2.2 | 6.7 | GO:0043293 | apoptosome(GO:0043293) |
2.0 | 8.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
2.0 | 20.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
1.9 | 7.8 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
1.9 | 11.3 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
1.9 | 5.6 | GO:0048179 | activin receptor complex(GO:0048179) |
1.8 | 7.1 | GO:0016342 | catenin complex(GO:0016342) |
1.8 | 30.1 | GO:0005614 | interstitial matrix(GO:0005614) |
1.8 | 7.0 | GO:0071953 | elastic fiber(GO:0071953) |
1.7 | 3.4 | GO:0072534 | perineuronal net(GO:0072534) |
1.7 | 13.7 | GO:0005861 | troponin complex(GO:0005861) |
1.7 | 5.0 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
1.6 | 86.2 | GO:0032587 | ruffle membrane(GO:0032587) |
1.6 | 4.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
1.5 | 4.6 | GO:0097513 | myosin II filament(GO:0097513) |
1.5 | 2.9 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
1.4 | 5.5 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.3 | 9.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.3 | 1.3 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
1.3 | 5.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
1.3 | 11.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.2 | 6.0 | GO:0016460 | myosin II complex(GO:0016460) |
1.2 | 20.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.2 | 4.8 | GO:0070876 | SOSS complex(GO:0070876) |
1.2 | 7.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.2 | 3.5 | GO:0005606 | laminin-1 complex(GO:0005606) |
1.2 | 14.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.2 | 4.6 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.1 | 9.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.1 | 6.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.1 | 5.5 | GO:0061617 | MICOS complex(GO:0061617) |
1.1 | 5.4 | GO:0089701 | U2AF(GO:0089701) |
1.1 | 3.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.1 | 6.4 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
1.1 | 12.7 | GO:0071564 | npBAF complex(GO:0071564) |
1.0 | 7.2 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
1.0 | 14.4 | GO:0005865 | striated muscle thin filament(GO:0005865) |
1.0 | 7.1 | GO:0016600 | flotillin complex(GO:0016600) |
1.0 | 8.0 | GO:0001520 | outer dense fiber(GO:0001520) |
1.0 | 6.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.0 | 1.9 | GO:0070852 | cell body fiber(GO:0070852) |
0.9 | 6.6 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.9 | 16.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.9 | 3.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.9 | 2.7 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.9 | 2.7 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.9 | 13.5 | GO:0034706 | sodium channel complex(GO:0034706) |
0.9 | 12.5 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.9 | 4.5 | GO:0099738 | cell cortex region(GO:0099738) |
0.9 | 6.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.9 | 3.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.9 | 8.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.9 | 6.0 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.8 | 14.0 | GO:0097225 | sperm midpiece(GO:0097225) |
0.8 | 3.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.8 | 8.9 | GO:0035102 | PRC1 complex(GO:0035102) |
0.8 | 6.3 | GO:0045179 | apical cortex(GO:0045179) |
0.8 | 3.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.8 | 2.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.8 | 3.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.8 | 6.9 | GO:0036156 | inner dynein arm(GO:0036156) |
0.8 | 2.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.7 | 10.4 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.7 | 1.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.7 | 2.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.7 | 3.6 | GO:0043194 | axon initial segment(GO:0043194) |
0.7 | 0.7 | GO:0033010 | paranodal junction(GO:0033010) |
0.7 | 2.1 | GO:0070938 | contractile ring(GO:0070938) |
0.7 | 3.4 | GO:0030673 | axolemma(GO:0030673) |
0.7 | 4.8 | GO:0043083 | synaptic cleft(GO:0043083) |
0.7 | 10.9 | GO:0051233 | spindle midzone(GO:0051233) |
0.7 | 1.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.7 | 4.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.7 | 0.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.7 | 2.0 | GO:0071942 | XPC complex(GO:0071942) |
0.6 | 7.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.6 | 5.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.6 | 25.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.6 | 8.2 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.6 | 3.1 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.6 | 1.9 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.6 | 1.8 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.6 | 14.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.6 | 1.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.6 | 4.8 | GO:0043196 | varicosity(GO:0043196) |
0.6 | 6.6 | GO:0032426 | stereocilium tip(GO:0032426) |
0.6 | 0.6 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.6 | 2.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.6 | 2.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.6 | 2.9 | GO:0071546 | pi-body(GO:0071546) |
0.6 | 4.7 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.6 | 36.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.6 | 1.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.5 | 1.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.5 | 1.6 | GO:0035838 | growing cell tip(GO:0035838) |
0.5 | 7.6 | GO:0005605 | basal lamina(GO:0005605) |
0.5 | 29.0 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.5 | 4.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.5 | 2.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.5 | 1.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.5 | 7.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.5 | 2.5 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.5 | 8.5 | GO:0030057 | desmosome(GO:0030057) |
0.5 | 30.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.5 | 1.0 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.5 | 1.9 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.5 | 4.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.5 | 17.0 | GO:0045171 | intercellular bridge(GO:0045171) |
0.5 | 4.2 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.5 | 4.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.5 | 5.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.5 | 1.4 | GO:0000802 | transverse filament(GO:0000802) |
0.5 | 0.5 | GO:0034705 | potassium channel complex(GO:0034705) |
0.5 | 43.3 | GO:0043204 | perikaryon(GO:0043204) |
0.5 | 1.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.5 | 4.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.5 | 5.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 1.8 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.4 | 8.0 | GO:0005922 | connexon complex(GO:0005922) |
0.4 | 0.9 | GO:0042588 | zymogen granule(GO:0042588) |
0.4 | 1.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.4 | 2.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.4 | 1.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.4 | 1.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.4 | 0.4 | GO:0030478 | actin cap(GO:0030478) |
0.4 | 3.8 | GO:0043034 | costamere(GO:0043034) |
0.4 | 0.8 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.4 | 6.4 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.4 | 4.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.4 | 3.9 | GO:0001741 | XY body(GO:0001741) |
0.4 | 1.2 | GO:0005688 | U6 snRNP(GO:0005688) |
0.4 | 2.6 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.4 | 1.5 | GO:0005955 | calcineurin complex(GO:0005955) |
0.4 | 4.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.4 | 2.1 | GO:0032982 | myosin filament(GO:0032982) |
0.4 | 1.1 | GO:1990393 | 3M complex(GO:1990393) |
0.4 | 27.1 | GO:0043296 | apical junction complex(GO:0043296) |
0.4 | 1.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.3 | 17.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 1.4 | GO:0097433 | dense body(GO:0097433) |
0.3 | 13.1 | GO:0045095 | keratin filament(GO:0045095) |
0.3 | 4.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.3 | 11.7 | GO:0072686 | mitotic spindle(GO:0072686) |
0.3 | 0.3 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.3 | 4.0 | GO:0097546 | ciliary base(GO:0097546) |
0.3 | 0.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.3 | 1.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 3.6 | GO:0000800 | lateral element(GO:0000800) |
0.3 | 2.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 1.9 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 0.9 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.3 | 1.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.3 | 3.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.3 | 2.2 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.3 | 99.3 | GO:0031012 | extracellular matrix(GO:0031012) |
0.3 | 0.6 | GO:0071547 | piP-body(GO:0071547) |
0.3 | 1.8 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.3 | 0.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 1.2 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.3 | 0.9 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.3 | 0.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.3 | 1.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 3.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.3 | 0.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 0.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.3 | 1.9 | GO:0016272 | prefoldin complex(GO:0016272) |
0.3 | 2.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 3.8 | GO:0031672 | A band(GO:0031672) |
0.3 | 9.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 2.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.3 | 1.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 2.9 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.3 | 0.3 | GO:0044393 | microspike(GO:0044393) |
0.3 | 0.8 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 1.3 | GO:0001652 | granular component(GO:0001652) |
0.3 | 0.8 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.3 | 8.3 | GO:0032432 | actin filament bundle(GO:0032432) |
0.3 | 1.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 8.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.3 | 2.3 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.3 | 1.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 0.5 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 6.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 0.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 0.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 0.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 0.5 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 1.4 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 0.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 1.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 0.5 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.2 | 0.9 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 2.2 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 8.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 0.7 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 0.9 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 2.4 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 0.4 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.2 | 3.7 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 0.7 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 0.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 7.5 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 1.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 3.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 7.0 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.2 | 0.6 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 6.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 2.4 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 4.6 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 1.0 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 1.6 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.2 | 5.4 | GO:0005844 | polysome(GO:0005844) |
0.2 | 2.3 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.2 | 5.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.2 | 0.6 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 3.2 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 9.2 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 54.7 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.2 | 0.2 | GO:1990696 | USH2 complex(GO:1990696) |
0.2 | 1.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 0.4 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 2.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 40.2 | GO:0005912 | adherens junction(GO:0005912) |
0.2 | 0.4 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.2 | 1.4 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.2 | 0.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 13.6 | GO:0030427 | site of polarized growth(GO:0030427) |
0.2 | 5.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.2 | 1.3 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 8.5 | GO:0005882 | intermediate filament(GO:0005882) |
0.2 | 1.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 1.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 14.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 2.3 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.5 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 0.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 5.6 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.5 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 1.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.1 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.1 | 1.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 1.6 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.2 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 1.9 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.4 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 16.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 2.7 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 1.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 0.1 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 3.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.4 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.4 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.7 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 1.4 | GO:0005903 | brush border(GO:0005903) |
0.1 | 3.2 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 0.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 1.9 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.2 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.0 | 0.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 2.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.0 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.0 | GO:1903349 | omegasome membrane(GO:1903349) omegasome(GO:1990462) |
0.0 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.0 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.0 | 0.3 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.5 | 34.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
6.9 | 27.5 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
6.2 | 18.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
6.1 | 24.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
5.9 | 29.4 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
5.8 | 75.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
5.3 | 15.9 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
5.3 | 15.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
4.8 | 14.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
4.7 | 18.8 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
4.4 | 35.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
4.3 | 17.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
4.1 | 12.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
4.1 | 12.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.9 | 7.8 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
3.8 | 11.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
3.8 | 11.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
3.7 | 22.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
3.5 | 17.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
3.4 | 20.3 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
3.2 | 12.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
3.0 | 9.0 | GO:0048030 | disaccharide binding(GO:0048030) |
3.0 | 9.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
2.9 | 8.6 | GO:0030172 | troponin C binding(GO:0030172) |
2.8 | 13.9 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
2.8 | 19.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.7 | 8.2 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.7 | 10.6 | GO:0098821 | BMP receptor activity(GO:0098821) |
2.6 | 7.9 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
2.6 | 10.5 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
2.6 | 7.7 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
2.5 | 10.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.5 | 2.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
2.5 | 22.4 | GO:0038191 | neuropilin binding(GO:0038191) |
2.5 | 7.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
2.4 | 14.2 | GO:0016936 | galactoside binding(GO:0016936) |
2.3 | 7.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
2.3 | 11.5 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
2.3 | 6.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
2.2 | 22.5 | GO:0070411 | I-SMAD binding(GO:0070411) |
2.2 | 13.4 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
2.2 | 22.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
2.2 | 17.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
2.2 | 8.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
2.1 | 6.4 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
2.1 | 6.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
2.1 | 6.3 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
2.1 | 12.6 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
2.1 | 6.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
2.0 | 14.2 | GO:0030957 | Tat protein binding(GO:0030957) |
2.0 | 12.0 | GO:0034711 | inhibin binding(GO:0034711) |
2.0 | 10.0 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
2.0 | 21.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.9 | 7.8 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.9 | 9.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.9 | 7.7 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
1.9 | 5.7 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
1.9 | 7.5 | GO:0031433 | telethonin binding(GO:0031433) |
1.9 | 1.9 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.9 | 5.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
1.8 | 9.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.8 | 18.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
1.8 | 5.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.8 | 9.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.8 | 18.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
1.8 | 1.8 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
1.8 | 10.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
1.8 | 19.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
1.8 | 8.9 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
1.8 | 8.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.7 | 7.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
1.7 | 8.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
1.7 | 6.7 | GO:0070052 | collagen V binding(GO:0070052) |
1.7 | 5.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.7 | 33.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
1.7 | 5.0 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
1.7 | 5.0 | GO:0042731 | PH domain binding(GO:0042731) |
1.7 | 1.7 | GO:0043426 | MRF binding(GO:0043426) |
1.6 | 4.9 | GO:1990254 | keratin filament binding(GO:1990254) |
1.6 | 4.9 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.6 | 9.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.6 | 6.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.6 | 7.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.6 | 3.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
1.5 | 4.6 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
1.5 | 7.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
1.5 | 3.0 | GO:0019959 | interleukin-8 binding(GO:0019959) |
1.5 | 1.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
1.5 | 8.7 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
1.4 | 5.8 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
1.4 | 4.3 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
1.4 | 2.8 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
1.4 | 5.7 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
1.4 | 4.2 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
1.4 | 21.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
1.4 | 4.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
1.4 | 4.1 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
1.4 | 41.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
1.3 | 13.4 | GO:0017166 | vinculin binding(GO:0017166) |
1.3 | 33.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
1.3 | 4.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
1.3 | 4.0 | GO:0055100 | adiponectin binding(GO:0055100) |
1.3 | 10.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
1.3 | 2.6 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
1.3 | 3.8 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.3 | 27.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
1.2 | 2.5 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
1.2 | 2.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.2 | 3.7 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.2 | 16.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
1.2 | 4.9 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
1.2 | 4.9 | GO:0097001 | ceramide binding(GO:0097001) |
1.2 | 4.9 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
1.2 | 8.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
1.2 | 6.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.2 | 4.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.2 | 3.6 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
1.2 | 18.0 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
1.2 | 6.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.2 | 2.4 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
1.2 | 15.5 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
1.2 | 4.7 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
1.2 | 1.2 | GO:0008517 | folic acid transporter activity(GO:0008517) |
1.2 | 9.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
1.2 | 3.5 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.1 | 12.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
1.1 | 6.8 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
1.1 | 7.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
1.1 | 5.6 | GO:0031419 | cobalamin binding(GO:0031419) |
1.1 | 3.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
1.1 | 3.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
1.1 | 5.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.1 | 17.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
1.1 | 4.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
1.0 | 4.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.0 | 3.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.0 | 7.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.0 | 9.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.0 | 6.0 | GO:0050733 | RS domain binding(GO:0050733) |
1.0 | 5.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.0 | 6.9 | GO:0031432 | titin binding(GO:0031432) |
1.0 | 13.7 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
1.0 | 2.0 | GO:0032052 | bile acid binding(GO:0032052) |
1.0 | 5.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
1.0 | 2.9 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
1.0 | 2.9 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.0 | 2.9 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
1.0 | 11.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.9 | 0.9 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.9 | 8.5 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.9 | 2.8 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.9 | 2.8 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.9 | 8.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.9 | 3.7 | GO:0030984 | kininogen binding(GO:0030984) |
0.9 | 10.0 | GO:0005542 | folic acid binding(GO:0005542) |
0.9 | 4.5 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.9 | 0.9 | GO:0016361 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
0.9 | 2.7 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.9 | 2.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.9 | 0.9 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.9 | 15.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.9 | 3.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.9 | 7.8 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.9 | 10.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.9 | 12.1 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.9 | 17.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.9 | 0.9 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.8 | 2.5 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.8 | 28.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.8 | 5.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.8 | 0.8 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.8 | 2.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.8 | 8.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.8 | 9.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.8 | 3.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.8 | 10.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.8 | 1.6 | GO:0045340 | mercury ion binding(GO:0045340) |
0.8 | 3.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.8 | 2.3 | GO:0019002 | GMP binding(GO:0019002) |
0.8 | 7.8 | GO:0031489 | myosin V binding(GO:0031489) |
0.8 | 42.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.8 | 6.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.8 | 2.3 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.8 | 2.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.8 | 1.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.8 | 0.8 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.8 | 2.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.8 | 2.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.8 | 1.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.8 | 11.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.8 | 0.8 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.8 | 18.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.8 | 3.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.8 | 2.3 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.7 | 4.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.7 | 14.9 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.7 | 3.7 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.7 | 2.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.7 | 2.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.7 | 10.2 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.7 | 3.6 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.7 | 11.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.7 | 7.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.7 | 0.7 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.7 | 2.9 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.7 | 2.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.7 | 2.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.7 | 2.8 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.7 | 9.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.7 | 1.4 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.7 | 28.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.7 | 8.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.7 | 1.4 | GO:0035939 | microsatellite binding(GO:0035939) |
0.7 | 5.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.7 | 16.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.7 | 18.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.7 | 0.7 | GO:0035671 | enone reductase activity(GO:0035671) |
0.7 | 2.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.7 | 2.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.7 | 2.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.7 | 2.6 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.7 | 2.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.7 | 1.3 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.7 | 12.5 | GO:0030332 | cyclin binding(GO:0030332) |
0.6 | 4.5 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.6 | 6.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.6 | 8.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.6 | 1.9 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.6 | 1.9 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.6 | 0.6 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.6 | 0.6 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.6 | 8.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.6 | 10.0 | GO:0005112 | Notch binding(GO:0005112) |
0.6 | 3.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.6 | 3.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.6 | 11.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.6 | 1.8 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.6 | 1.8 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.6 | 4.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.6 | 1.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.6 | 1.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.6 | 14.9 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.6 | 1.8 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.6 | 10.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.6 | 0.6 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.6 | 4.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.6 | 2.9 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.6 | 10.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.6 | 1.7 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.6 | 2.8 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.6 | 2.2 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.6 | 1.1 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.6 | 16.1 | GO:0015485 | cholesterol binding(GO:0015485) |
0.6 | 1.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.5 | 1.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.5 | 0.5 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
0.5 | 1.6 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.5 | 1.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.5 | 7.6 | GO:0008143 | poly(A) binding(GO:0008143) |
0.5 | 1.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.5 | 1.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.5 | 5.9 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.5 | 2.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.5 | 1.6 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.5 | 2.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.5 | 0.5 | GO:0051373 | FATZ binding(GO:0051373) |
0.5 | 5.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.5 | 2.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.5 | 3.7 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.5 | 3.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.5 | 1.5 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.5 | 5.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.5 | 1.5 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.5 | 2.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.5 | 1.0 | GO:0030546 | receptor activator activity(GO:0030546) |
0.5 | 10.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.5 | 2.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.5 | 3.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.5 | 2.0 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.5 | 4.9 | GO:0031005 | filamin binding(GO:0031005) |
0.5 | 1.5 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.5 | 4.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.5 | 1.9 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.5 | 3.8 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.5 | 3.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.5 | 3.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.5 | 0.9 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.5 | 1.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.5 | 5.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.5 | 1.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.5 | 1.4 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.5 | 2.7 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.5 | 7.7 | GO:0030552 | cAMP binding(GO:0030552) |
0.5 | 9.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.5 | 2.7 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.4 | 5.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.4 | 1.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.4 | 2.2 | GO:0034793 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.4 | 1.3 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.4 | 1.3 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.4 | 0.4 | GO:2001070 | starch binding(GO:2001070) |
0.4 | 3.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.4 | 14.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.4 | 7.0 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.4 | 7.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.4 | 1.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.4 | 2.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.4 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.4 | 26.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.4 | 4.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.4 | 12.5 | GO:0019894 | kinesin binding(GO:0019894) |
0.4 | 3.0 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.4 | 1.7 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.4 | 2.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.4 | 1.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 0.4 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.4 | 2.6 | GO:0035198 | miRNA binding(GO:0035198) |
0.4 | 1.7 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.4 | 3.0 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.4 | 0.8 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.4 | 2.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 2.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.4 | 3.7 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.4 | 4.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.4 | 9.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.4 | 2.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.4 | 2.0 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.4 | 0.8 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.4 | 2.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.4 | 8.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.4 | 1.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.4 | 1.6 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.4 | 1.2 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.4 | 0.4 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.4 | 2.4 | GO:0048156 | tau protein binding(GO:0048156) |
0.4 | 2.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.4 | 3.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.4 | 2.0 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.4 | 34.8 | GO:0008201 | heparin binding(GO:0008201) |
0.4 | 0.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.4 | 4.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.4 | 1.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.4 | 1.5 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.4 | 0.7 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.4 | 2.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.4 | 1.8 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.4 | 0.7 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.4 | 2.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.4 | 2.9 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.4 | 0.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 2.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.4 | 9.6 | GO:0008009 | chemokine activity(GO:0008009) |
0.4 | 11.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.4 | 2.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.4 | 4.2 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) |
0.4 | 1.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 7.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 1.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.3 | 2.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 0.3 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.3 | 2.0 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.3 | 6.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 1.0 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 2.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 1.0 | GO:0004103 | choline kinase activity(GO:0004103) |
0.3 | 89.0 | GO:0003779 | actin binding(GO:0003779) |
0.3 | 0.3 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.3 | 0.7 | GO:0005165 | neurotrophin receptor binding(GO:0005165) neurotrophin TRK receptor binding(GO:0005167) |
0.3 | 3.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.3 | 6.5 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.3 | 1.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.3 | 1.0 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.3 | 1.0 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.3 | 1.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.3 | 1.0 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.3 | 1.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 3.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.3 | 1.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 0.3 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.3 | 12.4 | GO:0035064 | methylated histone binding(GO:0035064) |
0.3 | 0.6 | GO:0032190 | acrosin binding(GO:0032190) |
0.3 | 0.9 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 1.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 6.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.3 | 1.8 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.3 | 0.9 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.3 | 0.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 1.7 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 2.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.3 | 0.3 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.3 | 0.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 1.4 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.3 | 0.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 2.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 1.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 1.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 0.5 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.3 | 2.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.3 | 1.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.3 | 0.8 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.3 | 0.8 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.3 | 12.1 | GO:0019003 | GDP binding(GO:0019003) |
0.3 | 1.5 | GO:0042805 | actinin binding(GO:0042805) |
0.3 | 1.8 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.3 | 3.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 2.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.3 | 8.8 | GO:0019111 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.3 | 0.5 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.3 | 2.5 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 0.5 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.2 | 0.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 3.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 1.5 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
0.2 | 0.7 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 1.0 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 2.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 2.2 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.2 | 0.5 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.2 | 1.0 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 0.5 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 0.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.2 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 0.5 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 0.9 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 2.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 0.9 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 3.2 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.2 | 2.7 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 19.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.2 | 2.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 0.4 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 0.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 3.7 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 2.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 0.4 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 0.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 1.1 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 9.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 0.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 0.9 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 0.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.2 | 1.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 0.4 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
0.2 | 0.6 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 0.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.8 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 1.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 3.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.2 | 1.0 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.2 | 0.8 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 1.8 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.2 | 0.2 | GO:0004854 | aldehyde oxidase activity(GO:0004031) xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.2 | 1.0 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 11.8 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.2 | 0.6 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.2 | 3.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 0.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 1.4 | GO:0070694 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.2 | 0.4 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.2 | 0.2 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.2 | 19.7 | GO:0005179 | hormone activity(GO:0005179) |
0.2 | 0.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 0.6 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.2 | 0.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 0.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 4.1 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.2 | 0.6 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.2 | 0.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 0.5 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.2 | 0.9 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 0.5 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.2 | 0.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.2 | 0.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 1.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 5.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 0.3 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 0.2 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 0.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 14.2 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) |
0.2 | 9.1 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.2 | 0.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 0.5 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 0.5 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 0.3 | GO:0048185 | activin binding(GO:0048185) |
0.2 | 1.3 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 20.0 | GO:0008017 | microtubule binding(GO:0008017) |
0.2 | 0.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 5.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 0.5 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 1.5 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 0.3 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.2 | 0.5 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 0.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 52.3 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.1 | 2.1 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.7 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 1.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 3.0 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 1.1 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 2.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 1.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.3 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.3 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.6 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 2.6 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.1 | 1.4 | GO:0022840 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.1 | 0.2 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.3 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 1.8 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.1 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 2.2 | GO:0034792 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.1 | 0.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.9 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 0.8 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.5 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 1.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.3 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 0.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.1 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.5 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.8 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.1 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 4.6 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.2 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 2.9 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.5 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 1.1 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 1.4 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.6 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 1.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.1 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.5 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.0 | GO:0001012 | RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.0 | 0.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.0 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.5 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 2.9 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.0 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
0.0 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 1.8 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.4 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.0 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.1 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.0 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 1.2 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.3 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.3 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 0.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.0 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.0 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.0 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
0.0 | 0.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 1.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.0 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 24.4 | PID ALK2 PATHWAY | ALK2 signaling events |
1.8 | 57.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.8 | 26.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.6 | 25.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.5 | 39.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
1.5 | 16.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.4 | 16.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
1.3 | 21.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
1.3 | 36.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
1.3 | 26.8 | PID REELIN PATHWAY | Reelin signaling pathway |
1.3 | 1.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.1 | 1.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.0 | 29.6 | PID RAS PATHWAY | Regulation of Ras family activation |
1.0 | 9.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.0 | 3.0 | PID EPO PATHWAY | EPO signaling pathway |
1.0 | 16.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.0 | 24.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.0 | 11.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.9 | 7.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.9 | 22.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.9 | 15.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.9 | 32.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.9 | 7.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.9 | 8.7 | PID IGF1 PATHWAY | IGF1 pathway |
0.9 | 19.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.9 | 31.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.9 | 0.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.8 | 9.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.8 | 11.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.8 | 22.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.8 | 26.2 | PID BMP PATHWAY | BMP receptor signaling |
0.8 | 17.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.8 | 7.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.8 | 14.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.8 | 35.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.7 | 15.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.7 | 11.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.7 | 9.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.7 | 4.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.7 | 33.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.7 | 19.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.7 | 10.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.6 | 6.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.6 | 8.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.6 | 1.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.6 | 7.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.6 | 17.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.6 | 1.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.5 | 72.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.5 | 6.9 | PID FGF PATHWAY | FGF signaling pathway |
0.5 | 64.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.5 | 2.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.5 | 1.9 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.5 | 1.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.5 | 2.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 12.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.4 | 11.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.4 | 4.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 10.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.4 | 90.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.4 | 13.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.4 | 3.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.4 | 4.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 5.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 11.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 0.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 0.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 1.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.3 | 1.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 0.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 0.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 1.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 1.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 0.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 4.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 1.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 4.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 1.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 0.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 3.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 1.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 0.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 10.0 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.1 | 0.8 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 49.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
3.0 | 44.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
2.7 | 11.0 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
2.5 | 37.0 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
2.3 | 50.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
2.1 | 26.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.8 | 40.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.7 | 20.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
1.7 | 16.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
1.5 | 15.0 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
1.5 | 13.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
1.5 | 13.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.4 | 44.5 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
1.4 | 22.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
1.3 | 14.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.3 | 2.6 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
1.3 | 25.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.3 | 24.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
1.3 | 13.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
1.2 | 3.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
1.2 | 14.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.2 | 22.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
1.2 | 14.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
1.2 | 9.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.1 | 1.1 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
1.1 | 15.5 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
1.0 | 12.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
1.0 | 2.0 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
1.0 | 22.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.0 | 21.0 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.9 | 2.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.9 | 12.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.9 | 26.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.9 | 18.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.9 | 6.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.9 | 6.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.9 | 11.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.9 | 9.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.8 | 11.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.8 | 6.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.8 | 7.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.8 | 6.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.8 | 1.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.8 | 8.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.8 | 0.8 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.7 | 11.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.7 | 0.7 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.7 | 6.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.7 | 9.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.7 | 14.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.7 | 23.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.7 | 18.5 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.6 | 26.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.6 | 9.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.6 | 6.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.6 | 1.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.6 | 3.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.6 | 21.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.6 | 1.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.5 | 4.2 | REACTOME OPSINS | Genes involved in Opsins |
0.5 | 1.0 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.5 | 5.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.5 | 51.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.5 | 4.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.5 | 11.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.5 | 3.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.5 | 4.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.5 | 3.8 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.5 | 2.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.4 | 6.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.4 | 8.9 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.4 | 7.2 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.4 | 1.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 0.4 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.4 | 9.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.4 | 3.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.4 | 2.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.4 | 4.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 1.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.4 | 0.8 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.4 | 9.5 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.4 | 5.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.4 | 5.8 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.4 | 1.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 8.0 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.3 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.3 | 2.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 1.6 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.3 | 1.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.3 | 14.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.3 | 3.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 4.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.3 | 4.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.3 | 0.3 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.3 | 34.8 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.3 | 1.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 6.7 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.3 | 17.9 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.3 | 1.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.3 | 2.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 13.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 2.7 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.3 | 2.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 6.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.3 | 3.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.3 | 7.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 6.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 2.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 3.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 0.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 2.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 2.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 1.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 0.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 7.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 0.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 3.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 0.8 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 6.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.2 | 0.5 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 1.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 0.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 1.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 0.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 2.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 0.3 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.1 | 12.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 1.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 0.3 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.1 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 2.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 1.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 1.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 1.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.3 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 1.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 1.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 1.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.4 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 0.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 1.5 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 0.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 1.0 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.4 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 0.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 0.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 1.2 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 2.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 1.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 0.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 1.2 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
0.0 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.0 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.0 | 0.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.0 | REACTOME SEMAPHORIN INTERACTIONS | Genes involved in Semaphorin interactions |